Benzinga's Microcap Movers for Tuesday January 17, 2012

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Shares of Ku6 Media

, the Beijing online video company, rose 139% Thursday on 157 times the average daily volume. Ku6 Media announced Tuesday that it has entered into a definitive agreement with YouTube, a renowned international video-sharing website, which would allow Ku6's international users to view original videos from China through a new channel operated by YouTube. We believe that this partnership will allow Ku6 to expand its content offering into the international market. Ku6 plans to recruit a team to operate this channel to help grow its user base and revenues in the international market. Ku6 Media closed at $3.30 Tuesday.

Shares of DARA Biosciences

, the Raleigh, NC development-stage pharmaceutical company, rose 19% Thursday on 12 times the average daily volume. DARA announced Tuesday that it has acquired exclusive U.S. rights to sell Soltamox, a liquid formulation of tamoxifen for the treatment of breast cancer, through the acquisition of South Carolina-based specialty pharmaceutical company, Oncogenerix. Christopher Clement, CEO of Oncogenerix and former CEO of Savient Pharmaceuticals, will join DARA as a director and as Chief Operating Officer. DARA closed at $1.55 Tuesday.

Shares of Celldex Therapeutics

, the Needham, MA biopharmaceutical company, rose 17% Tuesday on 8.5 times the average daily volume. Celldex announced Tuesday that dosing has initiated in a Phase 1 study of its hematopoietic growth factor, CDX-301, in healthy subjects. The study is being conducted in collaboration with Rockefeller University. CDX-301 is soluble, recombinant human FMS-like tyrosine kinase 3 ligand and previous experience has shown that it increases the numbers and activity of blood stem cells and immune cells. Celldex Therapeutics closed at $3.70 Tuesday.